Year Book of Obstetrics, Gynecology, and Women's Health, Volume 2013

1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. General Issue - p. 11 5. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial - p. 12 6. Effect of Screening for Partner Violence on Women's Quality of Life: A Randomized Controlled Trial - p. 13 7. Opting out of abortion training: benefits of partial participation in a dedicated family planning rotation for ob-gyn residents - p. 14 8. Effect of abortion protesters on women's emotional response to abortion - p. 15 9. Risk factors for postpartum depression among abused and nonabused women - p. 16 10. Long-Term Outcomes of Cognitive–Behavioral Treatments for Posttraumatic Stress Disorder Among Female Rape Survivors - p. 17 11. Miscellaneous - p. 18 12. Promotion Rates for Assistant and Associate Professors in Obstetrics and Gynecology - p. 19 13. Reentry Into Clinical Practice in Obstetrics and Gynecology - p. 20 14. Women in Leadership Positions Within Obstetrics and Gynecology: Does the Past Explain the Present? - p. 21 15. Maternal/Fetal Physiology - p. 22 16. Exercise in pregnancy: Effect on fitness and obstetric outcomes—A randomized trial - p. 23 17. Association of Atypical Decelerations With Acidemia - p. 24 18. Performance of an automatic quantitative ultrasound analysis of the fetal lung to predict fetal lung maturity - p. 25 19. Is maternal posturing during labor efficient in preventing persistent occiput posterior position? A randomized controlled trial - p. 26 20. Application of Second-Stage Passive Descent in Morbidly Obese Women - p. 27 21. Does the presence of a Cesarean section scar influence the site of placental implantation and subsequent migration in future pregnancies: a prospective case–control study - p. 28 22. Early Origins of the Metabolic Syndrome: Role of Small Size at Birth, Early Postnatal Weight gain, and Adult IGF-I - p. 29 23. Pregnancy Modifies the Antibody Response to Trivalent Influenza Immunization - p. 30 24. Parental Screening/Diagnosis and Genetics - p. 31 25. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies - p. 32 26. Noninvasive Single-Exon Fetal RHD Determination in a Routine Screening Program in Early Pregnancy - p. 33 27. Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis - p. 34 28. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population - p. 35 29. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 - p. 36 30. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18 - p. 37 31. Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 - p. 38 32. Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay - p. 39 33. Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis - p. 40 34. Maternal Complications - p. 41 35. An Observational Study of the Fresh Frozen Plasma: Red Blood Cell Ratio in Postpartum Hemorrhage - p. 42 36. Management of Symptomatic Ureteral Calculi Complicating Pregnancy - p. 43 37. Risk of Uterine Rupture and Placenta Accreta With Prior Uterine Surgery Outside of the Lower Segment - p. 44 38. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study - p. 45 39. Epidemiology of Retained Placenta: Oxytocin as an Independent Risk Factor - p. 46 40. Uterine artery embolization for the management of secondary postpartum haemorrhage associated with placenta accreta - p. 47 41. Hospital versus outpatient care for preterm pre-labour rupture of membranes - p. 48 42. Light drinking in pregnancy and mid-childhood mental health and learning outcomes - p. 49 43. Bakri balloon for the management of postpartum hemorrhage - p. 50 44. Antenatal identification of major depressive disorder: a cohort study - p. 51 45. Maternal hypertensive disorders in pregnancy and self-reported cognitive impairment of the offspring 70 years later: the Helsinki Birth Cohort Study - p. 52 46. Trends in obstetric anal sphincter injuries and associated risk factors for vaginal singleton term births in New South Wales 2001–2009 - p. 53 47. Maternal, Perinatal, and Postneonatal Outcomes in Women With Chronic Heart Disease in Washington State - p. 54 48. Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy - p. 55 49. Transfusion practices in postpartum hemorrhage: a population-based study - p. 56 50. Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality - p. 57 51. Uterine compression sutures for postpartum hemorrhage: an overview - p. 58 52. Medical Complications - p. 59 53. Timing of screening for gestational diabetes mellitus in women with moderate and severe obesity - p. 60 54. Dextrose Saline Compared With Normal Saline Rehydration of Hyperemesis Gravidarum: A Randomized Controlled Trial - p. 61 55. Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes - p. 62 56. Catch-up growth in children born growth restricted to mothers with hypertensive disorders of pregnancy - p. 63 57. The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial - p. 64 58. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study - p. 65 59. Obstetric complications among US women with asthma - p. 66 60. Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes - p. 67 61. Diabetes and Obesity-Related Genes and the Risk of Neural Tube Defects in the National Birth Defects Prevention Study - p. 68 62. Fetal Complications - p. 69 63. Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus - p. 70 64. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT - p. 71 65. Light drinking in pregnancy and mid-childhood mental health and learning outcomes - p. 72 66. Risk of Autism Spectrum Disorders in Low Birth Weight and Small for Gestational Age Infants - p. 73 67. Risk factors and adverse pregnancy outcomes among births affected by velamentous umbilical cord insertion: a retrospective population-based register study - p. 74 68. Neonatal brachial plexus palsy with vaginal birth after cesarean delivery: a case-control study - p. 75 69. Prenatal Exposure to Mercury and Fish Consumption During Pregnancy and Attention-Deficit/Hyperactivity Disorder–Related Behavior in Children - p. 76 70. Karyotype versus Microarray Testing for Genetic Abnormalities after Stillbirth - p. 77 71. Uterine Synechiae and Pregnancy Complications - p. 78 72. Lower risk for Down syndrome associated with longer oral contraceptive use: a case–control study of women of advanced maternal age presenting for prenatal diagnosis - p. 79 73. The Continuing Challenge of Understanding, Preventing, and Treating Neural Tube Defects - p. 80 74. Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction - p. 81 75. Accurate prediction of pregnancy viability by means of a simple scoring system - p. 82 76. Preeclampsia - p. 83 77. Improving patient understanding of preeclampsia: a randomized controlled trial - p. 84 78. Cell-free fetal DNA and adverse outcome in low risk pregnancies - p. 85 79. Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia - p. 86 80. Periodontitis as a Risk Factor for Preeclampsia - p. 87 81. HIV - p. 88 82. Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy - p. 89 83. Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in Botswana - p. 90 84. Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy - p. 91 85. Infectious Disease - p. 92 86. Parvovirus B19 Infection in the First Trimester of Pregnancy and Risk of Fetal Loss: A Population-based Case-Control Study - p. 93 87. Antibiotic Prophylaxis in Premature Rupture of Membranes at Term: A Randomized Controlled Trial - p. 94 88. Methicillin-resistant Staphylococcus aureus colonization among women admitted for preterm delivery - p. 95 89. Hepatitis C Virus in Pregnancy - p. 96 90. Antepartum Survillance - p. 97 91. Outcomes of elective induction of labour compared with expectant management: population based study - p. 98 92. Can transabdominal ultrasound be used as a screening test for short cervical length? - p. 99 93. Can transabdominal ultrasound be used as a screening test for short cervical length? - p. 100 94. A Prospective Cohort Study of Partner Testing for Herpes Simplex Virus and Sexual Behavior During Pregnancy - p. 101 95. Congenital Toxoplasma Infection: Monthly Prenatal Screening Decreases Transmission Rate and Improves Clinical Outcome at Age 3 Years - p. 102 96. Maternal/Fetal Therapy - p. 103 97. Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease - p. 104 98. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant - p. 105 99. Oxytocin discontinuation during active labor in women who undergo labor induction - p. 106 100. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm - p. 107 101. Effect of Maintenance Tocolysis With Nifedipine in Threatened Preterm Labor on Perinatal Outcomes: A Randomized Controlled Trial - p. 108 102. Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxis - p. 109 103. Antibiotic Prophylaxis in Premature Rupture of Membranes at Term: A Randomized Controlled Trial - p. 110 104. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm - p. 111 105. Neonatal Outcomes After Gestational Exposure to Nitrofurantoin - p. 112 106. Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion - p. 113 107. Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination - p. 114 108. Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children - p. 115 109. Micronutrient Supplementation and Pregnancy Outcomes: Double-Blind Randomized Controlled Trial in China - p. 116 110. Operative Obstetrics - p. 117 111. Utility of the Bladder Flap at Cesarean Delivery: A Randomized Controlled Trial - p. 118 112. Phenylephrine Infusion Versus Bolus Regimens During Cesarean Delivery Under Spinal Anesthesia: A Double-Blind Randomized Clinical Trial to Assess Hemodynamic Changes - p. 119 113. Use of early transverse annular compression sutures for complete placenta previa during cesarean delivery - p. 120 114. A Single Preoperative Dose of Gabapentin Does Not Improve Postcesarean Delivery Pain Management: A Randomized, Double-Blind, Placebo-Controlled Dose-Finding Trial - p. 121 115. Comparison of 2 stitches vs 1 stitch for transvaginal cervical cerclage for preterm birth prevention - p. 122 116. Strategies to enhance assessment of the fetal head position before instrumental delivery: a survey of obstetric practice in the United Kingdom and Ireland - p. 123 117. Time interval from elective removal of cervical cerclage to onset of spontaneous labour - p. 124 118. Long-Term Effect of Infection Prevention Practices and Case Mix on Cesarean Surgical Site Infections - p. 125 119. Chlorhexidine-Alcohol Compared With Povidone-Iodine for Surgical-Site Antisepsis in Cesarean Deliveries - p. 126 120. Cost-Effectiveness of Trial of Labor After Previous Cesarean in a Minimally Biased Cohort - p. 127 121. Timing of Delivery and Adverse Outcomes in Term Singleton Repeat Cesarean Deliveries - p. 128 122. Multifetal Pregnancy - p. 129 123. Diffusion MRI Findings in Monochorionic Twin Pregnancies after Intrauterine Fetal Death - p. 130 124. Reduced versus nonreduced twin pregnancies: obstetric performance in a cohort of interventional conceptions - p. 131 125. Gestational age at delivery and perinatal outcomes of twin gestations - p. 132 126. Obstetric and neonatal outcomes of twin pregnancies conceived by assisted reproductive technology compared with twin pregnancies conceived spontaneously: a prospective follow-up study - p. 133 127. Adverse outcomes in twin pregnancies complicated by early vaginal bleeding - p. 134 128. Postpartum - p. 135 129. Resolution of Pain after Childbirth - p. 136 130. Newborn - p. 137 131. Severe small size for gestational age and cognitive function: catch-up phenomenon possible - p. 138 132. Effect of umbilical cord milking in term and near term infants: randomized control trial - p. 139 133. Cerebral Palsy and Neonatal Death in Term Singletons Born Small for Gestational Age - p. 140 134. Economics of antiretroviral treatment vs. circumcision for HIV prevention - p. 141 135. Cesarean section and development of the immune system in the offspring - p. 142 136. Genetic testing in benign familial epilepsies of the first year of life: Clinical and diagnostic significance - p. 143 137. Decreasing perinatal mortality in placental abruption - p. 144 138. Therapy - p. 145 139. The efficacy of early amniotomy in nulliparous labor induction: a randomized controlled trial - p. 146 140. Changes in the Indications for Scheduled Births to Reduce Nonmedically Indicated Deliveries Occurring Before 39 Weeks of Gestation - p. 147 141. Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality - p. 148 142. Combined Effects of Antenatal Receipt of Influenza Vaccine by Mothers and Pneumococcal Conjugate Vaccine Receipt by Infants: Results from a Randomized, Blinded, Controlled Trial - p. 149 143. Cerclage Pessary for Preventing Preterm Birth in Women with a Singleton Pregnancy and a Short Cervix at 20 to 24 Weeks: A Randomized Controlled Trial - p. 150 144. The efficacy of early amniotomy in nulliparous labor induction: a randomized controlled trial - p. 151 145. Exercise in Pregnancy: Effect on Fitness and Obstetric Outcomes—A Randomized Trial - p. 152 146. Nifedipine Compared With Atosiban for Treating Preterm Labor: A Randomized Controlled Trial - p. 153 147. Effect of Maintenance Tocolysis With Nifedipine in Threatened Preterm Labor on Perinatal Outcomes: A Randomized Controlled Trial - p. 154 148. Induction of labor compared to expectant management in low-risk women and associated perinatal outcomes - p. 155 149. Endocrinology - p. 156 150. A Randomized Double-Blinded Placebo-Controlled Trial on the Effect of Dehydroepiandrosterone for 16 Weeks on Ovarian Response Markers in Women with Primary Ovarian Insufficiency - p. 157 151. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome - p. 158 152. Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case–control study - p. 159 153. CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes - p. 160 154. Association of Abnormal Ovarian Reserve Parameters With a Higher Incidence of Aneuploid Blastocysts - p. 161 155. Cilostazol blocks pregnancy in naturally cycling mice - p. 162 156. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route - p. 163 157. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? - p. 164 158. Infertility - p. 165 159. Predictors of pregnancy and live birth after insemination in couples with unexplained or male-factor infertility - p. 166 160. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy - p. 167 161. Effect of different ultrasound contrast materials and temperatures on patient comfort during intrauterine and tubal assessment for infertility - p. 168 162. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage - p. 169 163. Fertility preservation in women of reproductive age with cancer - p. 170 164. First trimester assessment of Pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss - p. 171 165. Bacterial vaginosis and infertility: cause or association? - p. 172 166. Dyspareunia and sexual dysfunction in women seeking fertility treatment - p. 173 167. A genetic association study of NLRP2 and NLRP7 genes in idiopathic recurrent miscarriage - p. 174 168. Infertility and the risk of adverse pregnancy outcomes: a systematic review and meta-analysis - p. 175 169. “Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss - p. 176 170. Assisted Reproductive Technology - p. 177 171. Elective cryopreservation of all embryos with subsequent cryothaw embryo transfer in patients at risk for ovarian hyperstimulation syndrome reduces the risk of adverse obstetric outcomes: a preliminary study - p. 178 172. Reducing multiples: a mathematical formula that accurately predicts rates of singletons, twins, and higher-order multiples in women undergoing in vitro fertilization - p. 179 173. Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer - p. 180 174. The preconception diet is associated with the chance of ongoing pregnancy in women undergoing IVF/ICSI treatment - p. 181 175. Single embryo transfer reduces the risk of perinatal mortality, a population study - p. 182 176. GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial - p. 183 177. The effect of progesterone supplementation on pregnancy rates in controlled ovarian stimulation and intrauterine insemination cycles: a randomized prospective trial - p. 184 178. Genetic and physiological study of morphologically abnormal human zona pellucida - p. 185 179. Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer - p. 186 180. Are imprinting disorders more prevalent after human in vitro fertilization or intracytoplasmic sperm injection? - p. 187 181. In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services - p. 188 182. Morphologic abnormalities in 2-year-old children born after in vitro fertilization/intracytoplasmic sperm injection with preimplantation genetic screening: follow-up of a randomized controlled trial - p. 189 183. Single embryo transfer reduces the risk of perinatal mortality, a population study - p. 190 184. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection - p. 191 185. Perimplantation Diagnosis - p. 192 186. Microarray analysis reveals abnormal chromosomal complements in over 70% of 14 normally developing human embryos - p. 193 187. Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast: insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development - p. 194 188. Pediatric and Adolescent Gynecology - p. 196 189. Intrauterine Devices and Pelvic Inflammatory Disease Among Adolescents - p. 197 190. Sexuality - p. 198 191. Comparison of prevalence of hypoactive sexual desire disorder (HSDD) in women after five different hysterectomy procedures - p. 199 192. A Multidimensional Model of Sexual Health and Sexual and Prevention Behavior Among Adolescent Women - p. 200 193. Contraception - p. 201 194. Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women - p. 202 195. Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial - p. 203 196. Self-Administered Misoprostol or Placebo Before Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial - p. 204 197. A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms - p. 205 198. Preventing Unintended Pregnancies by Providing No-Cost Contraception - p. 206 199. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data - p. 207 200. Levonorgestrel Intrauterine System Versus Medical Therapy for Menorrhagia - p. 208 201. Continuation of the Etonogestrel Implant in Women Undergoing Immediate Postabortion Placement - p. 209 202. Cervical lidocaine for IUD insertional pain: a randomized controlled trial - p. 210 203. A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use - p. 211 204. Cost as a Barrier to Long-Acting Reversible Contraceptive (LARC) Use in Adolescents - p. 212 205. Emergency contraception — mechanisms of action - p. 213 206. Continuation of the Etonogestrel Implant in Women Undergoing Immediate Postabortion Placement - p. 214 207. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception - p. 215 208. Factors Associated With 12-Month Discontinuation Among Contraceptive Pill, Patch, and Ring Users - p. 216 209. Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial - p. 217 210. Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies - p. 218 211. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial - p. 219 212. New approaches to male non-hormonal contraception - p. 220 213. Contraceptive Failures in Overweight and Obese Combined Hormonal Contraceptive Users - p. 221 214. Neisseria gonorrhea and Chlamydia trachomatis Screening at Intrauterine Device Insertion and Pelvic Inflammatory Disease - p. 222 215. Abortion: Medical and Surgical - p. 223 216. Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14–16 weeks: a randomized trial - p. 224 217. Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study - p. 225 218. Vaginal acidity enhancement with a 3% acetic acid gel prior to misoprostol treatment for pregnancy termination in the midtrimester - p. 226 219. A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days - p. 227 220. Paracervical Block For Pain Control in First-Trimester Surgical Abortion: A Randomized Controlled Trial - p. 228 221. Clinical outcomes from a prospective study evaluating the role of ambulation during medical termination of pregnancy - p. 229 222. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review - p. 230 223. Effect of interpregnancy interval after a mifepristone-induced abortion on neonatal outcomes in subsequent pregnancy - p. 231 224. Significant Adverse Events and Outcomes After Medical Abortion - p. 232 225. Breast Health - p. 233 226. Accuracy and Value of Breast Ultrasound for Primary Imaging Evaluation of Symptomatic Women 30–39 Years of Age - p. 234 227. Risk of Malignancy in Palpable Solid Breast Masses Considered Probably Benign or Low Suspicion: Implications for Management - p. 235 228. Mammographic Density and Estimation of Breast Cancer Risk in Intermediate Risk Population - p. 236 229. Breast Imaging of the Pregnant and Lactating Patient: Physiologic Changes and Common Benign Entities - p. 237 230. Ectopic Pregnancy - p. 238 231. Medical therapy (methotrexate and mifepristone) alone or in combination with another type of therapy for the management of cervical or interstitial ectopic pregnancy - p. 239 232. Bilateral uterine artery chemoembolization with methotrexate for cesarean scar pregnancy - p. 240 233. Bilateral uterine artery chemoembolization with methotrexate for cesarean scar pregnancy - p. 241 234. Fertility after ectopic pregnancy: the DEMETER randomized trial - p. 242 235. Infectious Disease - p. 243 236. Neisseria gonorrhea and Chlamydia trachomatis Screening at Intrauterine Device Insertion and Pelvic Inflammatory Disease - p. 244 237. Fluconazole-Resistant Candida albicans Vulvovaginitis - p. 245 238. Lactobacilli vs Antibiotics to Prevent Urinary Tract Infections: A Randomized, Double-Blind, Noninferiority Trial in Postmenopausal Women - p. 246 239. An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator - p. 247 240. Fluconazole-Resistant Candida albicans Vulvovaginitis - p. 248 241. Chlamydia Public Health Programs and the Epidemiology of Pelvic Inflammatory Disease and Ectopic Pregnancy - p. 249 242. Ultrasound - p. 250 243. Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature - p. 251 244. Reevaluation of discriminatory and threshold levels for serum β-hCG in early pregnancy - p. 252 245. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? - p. 253 246. Surgery - p. 254 247. Minimally Invasive Endometrial Ablation Device Complications and Use Outside of the Manufacturers' Instructions - p. 255 248. Factors associated with complications and conversion to laparotomy in women undergoing laparoscopically assisted vaginal hysterectomy - p. 256 249. Ovarian reserve testing before and after laparoscopic tubal bipolar electrodesiccation and transection - p. 257 250. Pre-emptive analgesia by nerve stimulator guided pudendal nerve block for posterior colpoperineorrhaphy - p. 258 251. Real-time infrared thermography for ureter detection during hysterectomy - p. 259 252. The Learning Curve of Robotic Hysterectomy - p. 260 253. Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease - p. 261 254. Robot-Assisted Laparoscopic Myomectomy Compared With Standard Laparoscopic Myomectomy - p. 262 255. Obliterative LeFort Colpocleisis in a Large Group of Elderly Women - p. 263 256. Interest in cosmetic vulvar surgery and perception of vulvar appearance - p. 264 257. Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease - p. 265 258. Hysterectomy surgical trends: a more accurate depiction of the last decade? - p. 266 259. A comparison of 2 methods of vaginal cuff closure during robotic hysterectomy - p. 267 260. Postoperative Pain and Recovery After Conventional Laparoscopy Compared With Robotically Assisted Laparoscopy - p. 268 261. Ambulation of Hospitalized Gynecologic Surgical Patients: A Randomized Controlled Trial - p. 269 262. Outpatient Vaginal Hysterectomy: Optimizing Perioperative Management for Same-Day Discharge - p. 270 263. The Learning Curve of Robotic Hysterectomy - p. 271 264. The aromatase inhibitor letrozole reduces adhesion formation after intraperitoneal surgery in a rat uterine horn model - p. 272 265. Dexamethasone for Antiemesis in Laparoscopic Gynecologic Surgery: A Systematic Review and Meta-Analysis - p. 273 266. Cervics - p. 274 267. Clinical Significance of Serum Anti-Human Papillomavirus 16 and 18 Antibodies in Cervical Neoplasia - p. 275 268. Endometriosis - p. 276 269. Prevalence and Associated Factors of Female Sexual Dysfunction in Women With Endometriosis - p. 277 270. Aromatase inhibitors for the treatment of endometriosis - p. 278 271. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life - p. 279 272. Urogynecology - p. 280 273. Obstetrical anal sphincter laceration and anal incontinence 5-10 years after childbirth - p. 281 274. Neuromodulation for Fecal and Urinary Incontinence: Functional Results in 57 Consecutive Patients From a Single Institution - p. 282 275. Trends in the Surgical Management of Stress Urinary Incontinence - p. 283 276. Transobturator vaginal tape for the treatment of stress urinary incontinence in elderly women without concomitant pelvic organ prolapse: is it effective and safe? - p. 284 277. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder - p. 285 278. Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB) - p. 286 279. Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures - p. 287 280. Obstetrical anal sphincter laceration and anal incontinence 5-10 years after childbirth - p. 288 281. Continence outcomes following partial excision of vaginal mesh exposure after mid-urethral tape insertion - p. 289 282. Women's quality of life and sexual function after transvaginal anterior repair with mesh insertion - p. 290 283. Impact of childbirth and mode of delivery on vaginal resting pressure and on pelvic floor muscle strength and endurance - p. 291 284. Is there a high incidence of hysterectomy and other nonbladder surgeries before and after onset of interstitial cystitis/bladder pain syndrome? - p. 292 285. Trends in Surgical Mesh Use for Pelvic Organ Prolapse From 2000 to 2010 - p. 293 286. Menopause - p. 294 287. Efficacy of Cognitive Behavioral Therapy and Physical Exercise in Alleviating Treatment-Induced Menopausal Symptoms in Patients With Breast Cancer: Results of a Randomized, Controlled, Multicenter Trial - p. 295 288. Anti-Mullerian Hormone as a Predictor of Time to Menopause in Late Reproductive Age Women - p. 296 289. Ospemifene, vulvovaginal atrophy, and breast cancer - p. 297 290. Effect of Exercise Training Combined With Isoflavone Supplementation on Bone and Lipids in Postmenopausal Women: A Randomized Clinical Trial - p. 298 291. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial - p. 299 292. Leiomyoma - p. 300 293. Incidence and Risk Factors for Clinical Failure of Uterine Leiomyoma Embolization - p. 301 294. Treatment failure after uterine artery embolization: Prospective cohort study with multifactorial analysis of possible predictors of long-term outcome - p. 302 295. Uterine Artery Embolization of Large Fibroids: Comparative Study of Procedure With and Without Pretreatment Gonadotropin-Releasing Hormone Agonists - p. 303 296. Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy - p. 304 297. Levonorgestrel Intrauterine System versus Medical Therapy for Menorrhagia - p. 305 298. African Ancestry and Genetic Risk for Uterine Leiomyomata - p. 306 299. Surgical and Medical Oncology - p. 307 300. Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials - p. 308 301. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies - p. 309 302. Gonadatrophin Suppression to Prevent Chemotherapy-Induced Ovarian Damage: A Randomized Controlled Trial - p. 310 303. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies - p. 311 304. Analgesic and Antiemetic Requirements After Minimally Invasive Surgery for Early Cervical Cancer: A Comparison Between Laparoscopy and Robotic Surgery - p. 312 305. Early Diagnosis and Risk Factors for Lymphedema Following Lymph Node Dissection for Gynecologic Cancer - p. 313 306. Estrogen receptor prevents p53-dependent apoptosis in breast cancer - p. 314 307. Cancer Genetics and Screening Modalities - p. 315 308. Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm - p. 316 309. Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule - p. 317 310. Assessing the Risk of Ovarian Malignancy in Asymptomatic Women With Abnormal CA 125 and Transvaginal Ultrasound Scans in the Prostate, Lung, Colorectal, and Ovarian Screening Trial - p. 318 311. Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule - p. 319 312. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers - p. 320 313. Assessing the Risk of Ovarian Malignancy in Asymptomatic Women With Abnormal CA 125 and Transvaginal Ultrasound Scans in the Prostate, Lung, Colorectal, and Ovarian Screening Trial - p. 321 314. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique - p. 322 315. Vulva Vagina - p. 323 316. Prognostication of Vulvar Cancer Based on p14ARF Status: Molecular Assessment of Transcript and Protein - p. 324 317. Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream - p. 325 318. Cervix - p. 326 319. Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study - p. 327 320. Primary high-risk HPV screening for cervical cancer in post-menopausal women - p. 328 321. Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany - p. 329 322. 17β-Oestradiol activates proteolysis and increases invasion through phosphatidylinositol 3-kinase pathway in human cervical cancer cells - p. 330 323. Early-stage cervical cancer: Tumor delineation by magnetic resonance imaging and ultrasound – A European multicenter trial - p. 331 324. Uterus - p. 332 325. Outcome of investigations for postmenopausal vaginal bleeding in women under the age of 50 years - p. 333 326. Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome - p. 334 327. Combined use of preoperative transvaginal ultrasonography and intraoperative gross examination in the assessment of myometrial invasion in endometrial carcinoma - p. 335 328. Outcomes in women age 40 years and older with cytologically benign endometrial cells - p. 336 329. Fallopian Tube and Ovary - p. 337 330. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project - p. 338 331. Laparoscopic Staging of Early Ovarian Cancer: Results of a Multi-Institutional Cohort Study - p. 339 332. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome - p. 340 333. Systematic Para-aortic and Pelvic Lymphadenectomy in Early Stage Epithelial Ovarian Cancer: A Prospective Study - p. 341 334. Digital quantification of precursor frequency in the fallopian tube and its significance - p. 342 335. The effect of hysterectomy on survival of patients with borderline ovarian tumors - p. 343 336. Use of Fertility Drugs and Risk of Ovarian Cancer: Results from a U.S.-Based Case–Control Study - p. 344 337. Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens - p. 345 338. Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma - p. 346 339. 17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma - p. 347